Haisch A, Schultz O, Perka C, Jahnke V, Burmester G R, Sittinger M
HNO-Klinik und Poliklinik, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin.
HNO. 1996 Nov;44(11):624-9. doi: 10.1007/s001060050067.
Current practical approaches in cartilage engineering still face problems with three dimensional cell distribution or require components for cell immobilization, raising biocompatibility problems. In this study, we present a new model using cells cross-linked by fibrin within biocompatible resorbable polymers. Both components have been in clinical use for a long time. Immunohistochemical procedures showed that this model provides optimal requirements for in vitro cartilage production. Immunochemically, cartilage-specific extracellular components such as proteoglycan, chondroitin sulfate and collagen II were characterized. Histomorphological methods showed a mechanically stable tissue compound that lasted for at least 5 weeks. This model may be the first to provide all biocompatible requirements for in vitro production of autologous cartilage transplants for reconstructive surgery.